Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2005 2
2006 1
2007 7
2008 7
2009 3
2010 3
2011 5
2012 10
2013 12
2014 12
2015 12
2016 17
2017 10
2018 17
2019 12
2020 8
2021 10
2022 18
2023 25
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

171 results

Results by year

Filters applied: . Clear all
Page 1
Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.
Schlumberger M, Tahara M, Wirth LJ, Robinson B, Brose MS, Elisei R, Habra MA, Newbold K, Shah MH, Hoff AO, Gianoukakis AG, Kiyota N, Taylor MH, Kim SB, Krzyzanowska MK, Dutcus CE, de las Heras B, Zhu J, Sherman SI. Schlumberger M, et al. Among authors: krzyzanowska mk. N Engl J Med. 2015 Feb 12;372(7):621-30. doi: 10.1056/NEJMoa1406470. N Engl J Med. 2015. PMID: 25671254 Free article. Clinical Trial.
A Randomized Study of Lenvatinib 18 mg vs 24 mg in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer.
Brose MS, Panaseykin Y, Konda B, de la Fouchardiere C, Hughes BGM, Gianoukakis AG, Joo Park Y, Romanov I, Krzyzanowska MK, Leboulleux S, Binder TA, Dutcus C, Xie R, Taylor MH. Brose MS, et al. Among authors: krzyzanowska mk. J Clin Endocrinol Metab. 2022 Feb 17;107(3):776-787. doi: 10.1210/clinem/dgab731. J Clin Endocrinol Metab. 2022. PMID: 34664662 Free PMC article. Clinical Trial.
Drug interactions and oncological outcomes: a hidden adversary.
Riechelmann RP, Krzyzanowska MK. Riechelmann RP, et al. Among authors: krzyzanowska mk. Ecancermedicalscience. 2019 Mar 28;13:ed88. doi: 10.3332/ecancer.2019.ed88. eCollection 2019. Ecancermedicalscience. 2019. PMID: 31123502 Free PMC article.
Transitioning to a New Normal in the Post-COVID Era.
Jiang DM, Berlin A, Moody L, Kumar R, Hannon B, Krzyzanowska MK, Dhani N, Cole H, Elliott M, Sridhar SS. Jiang DM, et al. Among authors: krzyzanowska mk. Curr Oncol Rep. 2020 Jun 22;22(7):73. doi: 10.1007/s11912-020-00956-1. Curr Oncol Rep. 2020. PMID: 32566960 Free PMC article. Review. No abstract available.
Reply to F. Poizeau et al.
Eng L, Sutradhar R, Krzyzanowska MK. Eng L, et al. Among authors: krzyzanowska mk. J Clin Oncol. 2023 Nov 10;41(32):5073-5075. doi: 10.1200/JCO.23.01191. Epub 2023 Aug 23. J Clin Oncol. 2023. PMID: 37611213 No abstract available.
Incident Cancer Detection During the COVID-19 Pandemic.
Eskander A, Li Q, Yu J, Hallet J, Coburn NG, Dare A, Chan KKW, Singh S, Parmar A, Earle CC, Lapointe-Shaw L, Krzyzanowska MK, Hanna TP, Finelli A, Louie AV, Look Hong N, Irish JC, Witterick IJ, Mahar A, Noel CW, Urbach DR, McIsaac DI, Enepekides D, Sutradhar R. Eskander A, et al. Among authors: krzyzanowska mk. J Natl Compr Canc Netw. 2022 Feb 1;20(3):276-284. doi: 10.6004/jnccn.2021.7114. J Natl Compr Canc Netw. 2022. PMID: 35104788
171 results